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ZO-1
OccludinDisruption of epithelial barrier function was identiﬁed as one of the pathologic mechanisms in inﬂammatory
bowel diseases (IBD). Epithelial barrier consists of various intercellular junctions, in which the tight junction
(TJ) is an important component. However, the regulatory mechanism of tight junction is still not clear. Here
we examined the role of focal adhesion kinase (FAK) in the epithelial barrier function on Caco-2 monolayers
using a speciﬁc FAK inhibitor, PF-573, 228 (PF-228). We found that the decrease of transepithelial resistance
and the increase of paracellular permeability were accompanied with the inhibition of autophosphorylation
of FAK by PF-228 treatment. In addition, PF-228 inhibited the FAK phosphorylation at Y576/577 on activation
loop by Src, suggesting Src-dependent regulation of FAK in Caco-2 monolayers. In an ethanol-induced barrier
injury model, PF-228 treatment also inhibited the recovery of transepithelial resistance as well as these phos-
phorylations of FAK. In a sucrose gradient ultracentrifugation, FAK co-localized with claudin-1, an element of
the TJ complex, and they co-migrate after ethanol-induced barrier injury. Immunoﬂuorescence imaging anal-
ysis revealed that PF-228 inhibited the FAK redistribution to the cell border and reassembly of TJ proteins in
the recovery after ethanol-induced barrier injury. Finally, knockdown of FAK by siRNA resulted in the de-
crease of transepithelial resistance. These ﬁndings reveal that activation of FAK is necessary for maintaining
and repairing epithelial barrier in Caco-2 cell monolayer via regulating TJ redistribution.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Epithelial cells lining the lumens of gastrointestinal tract act as
selective physical barriers that regulate transepithelial movement of
solutes, ions, water and hostile substance. A number of recent studies
have suggested that defective intestinal epithelial barrier function
is an important pathogenic factor contributing to the development
of intestinal inﬂammation [1–3]. Although the pathogenesis of ulcera-
tive colitis (UC) and Crohn's disease, which are known as inﬂammatory
bowel diseases (IBD), remains unclear, a number of studies suggest that
the destruction of the gastrointestinal tract integrity by the alteration of
epithelial barrier function was identiﬁed as one of pathologic mecha-
nisms in IBD [4].
Epithelial barrier consists of various intercellular junctions, such
as adherens junction, gap junction, desmosome and tight junctionon, Department of Biochemis-
, Japan. Tel.: +81 166 68 2340;
aniguchi).
rights reserved.(TJ). The TJ is the most apical component of the epithelial junctional
complex [5], acting as gates of the paracellular pathway by controlling
the extent and selectivity of diffusion and as fences that keep the iden-
tity of plasma membrane domains by forming an apical–basolateral
intramembrane diffusion barrier [6]. TJ consists of transmembrane
proteins, such as claudin and occludin. These proteins form the
paracellular seals by interaction of extracellular domain with each
other, and the cytoplasmic plaque by interaction of intercellular domain
and various adaptor proteins, such as ZO-1. These adaptor proteins are
thought to be a linker connecting the transmembrane proteins and
the actin cytoskeletons [7]. TJ also have been linked to various signaling
molecules that are regulated by extracellular stimuli. Cytokines such
as TNFα and interferon-γ, which are considered playing a key role
in the pathogenesis of inﬂammatory disorders, disrupt TJ and barrier
functions to increase epithelial permeability in various epithelial mono-
layers [8–10]. Furthermore, TNFα and interferon-γ synergized to in-
duce TJ disruption and intestinal epithelial barrier dysfunction [11].
Although precise regulatory mechanism of TJ barrier functions is
still not clear, recent studies have demonstrated an important role
for focal adhesion kinase (FAK), which is a non-receptor protein tyro-
sine kinase, in modulating barrier function. Zhao et al. reported that
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wild type endothelial cell during embryonic development [12]. FAK
activity is necessary for barrier enhancement in endothelia [13,14].
Siu et al. have identiﬁed that FAK is an integrated component of
the occludin/ZO-1 complex that regulates cell adhesion by determin-
ing the phosphorylation status of occludin at the blood–testis barrier
[15,16]. These results are suggesting that FAK is required for mainte-
nance of TJ barrier functions via tyrosine phosphorylation of TJ
protein complex. Furthermore, Golubovskaya reported that transcrip-
tion of FAKwas regulated by NF-κB,which is known as “ﬁrst responder”
against various cytokines [17]. Aftermucosal injury, FAK protein expres-
sion in gut epithelial cells was enhanced via Smad- and p38-mediated
pathways [18]. We have also demonstrated that protein expression
level of FAK increased in colonic epithelial cells by inducing chemical
colitis [19]. These results suggest that FAK expression and functions
may regulate by various cytokines in pathological conditions, however,
the role of FAK in colonic epithelial cells remains unclear.
The purpose of this study was to examine the role of FAK on the
epithelial barrier function on Caco-2 monolayers. We investigated the
effect of FAK inhibitor, PF-573, 228 (PF-228) on barrier function in
Caco-2 monolayers. PF-228 is a small molecule FAK inhibitor, which
interacts with FAK in the ATP-binding pocket, and effectively blocks
the catalytic activity of FAK [20]. This compound is a useful tool to dis-
sect the role of FAK in regulation of cell adhesion signaling and dynam-
ics [20], in signaling pathways in human platelet [21], and in directional
motility of cells [22]. In this manuscript, we sought to ﬁnd the role
of FAK in intestinal epithelial barrier function by measuring changes
of transepithelial electrical resistance (TEER), paracellular permeability
and phosphorylation of FAK by PF-228 treatment and by knockdown
with siRNA. Furthermore, we determined the effect of PF-228 on distri-
bution of TJ proteins, ZO-1 and occludin. Our ﬁndings indicate that acti-
vation of FAK is necessary for maintaining and repairing epithelial
barrier in Caco-2 cell monolayer via regulating TJ redistribution.2. Materials and methods
2.1. Materials
Dulbecco's Modiﬁed Eagle's Medium (DMEM) and trypsin–EDTA
solution were purchased from Sigma (St. Louis, MO). Fetal bovine serum
(FBS) was from Invitrogen Life Technologies Corp. (Carlsbad, CA, USA).
The focal adhesion kinase (FAK) inhibitor PF-573, 228 (3,4-dihydro-6-
[[4-[[[3-(methyl-sulfonyl)phenyl]methyl]amino]-5-(triﬂuoromethyl)-2-
pyrimidinyl]amino]-2(1H)-quinolinone) was from Tocris (Bristol, UK).
Antibodies against total FAK, phosphorylated FAK at Tyr397, at Tyr576/
577, Src and claudin-1 were from Cell Signaling Technology (Danvers,
MA). For immunoﬂuorescence staining, anti-total FAK was purchased
from Calbiochem (Billerica, MA), anti-phosphorylated FAK at Tyr397
was from Abcam (Cambridge, UK) and anti-ZO-1 and anti-occludin an-
tibodies were from Invitrogen Life Technologies Corp.2.2. Cell culture
Caco-2 cells were purchased from the RIKEN Cell Bank (Tsukuba,
Japan). The cells were cultured in DMEM supplemented with 10%
FBS, 1% nonessential amino acids, 10 mM HEPES (pH 7.2), 100 U/ml
penicillin and 100 μg/ml streptomycin. The cells were grown in a hu-
midiﬁed atmosphere containing 5% CO2 at 37 °C. Culture medium
was changed every 2 days. For TEER study, Caco-2 cells were seeded
in cell culture inserts (Millicell-PCF, 0.4 μm pore size, 12 mm diameter,
Millipore, Ireland) in 24-well plates at a density of 1×105 cells/cm2. For
immunoﬂuorescence staining, Caco-2 cells were plated in 8-well
Millicell EZ slide (Merck Millipore, Billerica MA, USA) at 1.5×105 cells/
well in growth medium.2.3. Measurement of Caco-2 monolayer epithelial resistance and
paracellular permeability
Caco-2 cells were cultured for 3–4 weeks on Millicell culture inserts
to form a monolayer. TEER values across the cell monolayers were
measured using a Millicell ERS-2 epithelial volt-ohm meter (Merck
Millipore). For resistance measurements, both apical and basolateral
sides of the epithelia were bathed in culture medium. Inserts having
over 400 Ω·cm2 of TEER values were used for further experiments.
Each experiment was repeated at least 3 times to ensure reproducibili-
ty. The modulation of Caco-2 monolayer paracellular permeability by
ethanol treatment was carried out as established [23]. Brieﬂy, Caco-2
monolayers were incubated in DMEM containing 7.5% ethanol at
37 °C for 30 min. After removal of ethanol, monolayers were incubated
with culture medium and measured TEER at indicated time points.
For determination of lucifer yellow permeability, Caco-2 monolayers
were incubated for 4 h in the indicated concentration of PF-228.
After washed with HBSS, lucifer yellow was added to the apical com-
partment at a ﬁnal concentration of 1 mM. The monolayers were placed
on a shaker in a 37 °C incubator with a humidiﬁed atmosphere con-
taining 5% CO2 for 1 h. Fluorescence leakage was determined for lucifer
yellow by 430 nm excitation and 535 nm emission using a ﬂuorescence
spectrophotometer.2.4. Immunoprecipitation and Western blot
Immunoprecipitation was performed as described [24] with some
modiﬁcations. Caco-2 cells were lysed in immunoprecipitation buffer
(20 mM Tris–HCl (pH 7.5), 0.5 M NaCl, 1% TritonX-100, 2 mM EDTA,
50 mM NaF, 1 mM Na3VO4, 0.1% sodium dodecyl sulfate, 0.5% Nonidet
P-40, 1% TritonX-100 and10% glycerol (vol/vol)), containing protease in-
hibitor cocktail (Roche, Mannheim, Germany). After 4 cycles of freeze–
thaw and sonication, lysates were centrifuged at 12,000 g for 10 min.
The supernatant was incubated with anti-FAK antibody overnight.
The immunocomplex was then precipitated with protein G-Sepharose
beads (GE Healthcare). The immunocomplex was washed ﬁve times
with the immunoprecipitation buffer, eluted by boiling in sample buffer
for SDS-PAGE and Western blot was performed as described previously
[19]. About 1.4 mg protein in approximately 2 ml was used per sample
tube for immunoprecipitation.2.5. Immunoﬂuorescence and confocal microscopy
Caco-2 cells that were grown on 8-well glass slide chambers to
100% conﬂuence for 3–4 weeks were used. After treatment as indicat-
ed in the ﬁgures, cells were rinsed once with PBS, and ﬁxed with 3.7%
formaldehyde in phosphate buffered saline (PBS) for 15 min at room
temperature. Then cells were rinsed three times with PBS and perme-
abilized with 0.5% Triton X-100 in PBS for 10 min at room temperature.
After washing, cells were blocked in Image-IT FX signal enhancer
(Invitrogen Life Technologies Corp.) for 1 h at room temperature. And
then cells were incubated with respective primary antibodies to total
FAK (1:100), phosho-FAK at Y397 (1:100), ZO-1 (1:100), and occludin
(1:100) diluted in 0.5% Triton X-100 in PBS overnight at 4 °C. Subse-
quently the secondary antibodies, goat anti-rabbit IgG-Alexa 555 and
goat anti-mouse IgG-Alexa 488 (Invitrogen Life Technologies Corp.)
were diluted at 1:100 with PBS containing 0.5% Triton X-100 and incu-
bated with cells for 1 h at room temperature in the dark. Slides were
mounted in ProLong Gold antifade reagent with 4′, 6′-diamidino-
2-phenylindole (DAPI) (Invitrogen Life Technologies Corp.) to stain nu-
cleus. Cells were observed with confocal laser scanning microscope,
FV1000-D (Olympus, Tokyo, Japan) using a ×100 oil immersion objec-
tive and FV10-ASW software (Ver 3.0, Olympus).
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Detergent-insoluble membrane fractions were prepared as de-
scribed previously [25] with some modiﬁcations. Caco-2 cells were
lysed in 2 ml of lysis buffer (20 mM Tris–HCl, pH 7.4, 150 mM NaCl,
1% Triton X-100, 1 mM NaF, 1 mM Na3VO4 and protease inhibitors
cocktail) and removed nuclei and cellular debris by a low speed cen-
trifugation (500 g for 10 min). The supernatant was diluted with 80%
sucrose without detergent to a ﬁnal concentration of 40% sucrose.
Samples were placed at the bottom of a centrifuge tube and 2 ml
each of 35, 25, 15, and 5% sucrose in TBS was layered. After ultracen-
trifugation at 218,000 g for 18 h at 4 °C using Hitachi RPS40-T rotor,
the buoyant was collected as eight 1 ml fractions from the top. Each
fraction was diluted with 3 volumes of lysis buffer, and insoluble ma-
terial was pelleted by centrifugation (12,000 g for 20 min at 4 °C).
Resultant pellet was suspended in sample buffer for SDS-PAGE.
2.7. Knockdown of FAK by siRNA
We used predesigned siRNAs as follows: FAK, validated MISSION
siRNA (SASI_Hs01_00035697 and SASI_Hs01_00035698; Sigma-
Aldrich); and negative control, MISSION siRNAUniversal Negative Con-
trol (SIC-001; Sigma-Aldrich). Transient transfections of siRNA into
Caco-2 cells were performed using siLentFect Lipid Reagent (Bio-Rad
Laboratories, Hercules, CA) as described previously [26]. After transfec-
tion, the cells were cultured for 4 days on Millicell culture insert
to develop tight junction assembly and polarization before TEER mea-
surement and Western bolt experiments.
2.8. Statistical analysis
Results are expressed as means±SEM of n experiments. Statistical
signiﬁcance was evaluated using Student's t-test. pb0.05 was consid-
ered statistically signiﬁcant. The results shown are representative data
of at least three independent experiments.
3. Results
3.1. Inhibition of FAK activity by PF-228 impaired barrier function of
Caco-2 monolayers
To investigate the function of FAK on the barrier function of Caco-2
monolayers, we used a speciﬁc FAK inhibitor, PF-228, and evaluated
the monolayer permeability. We ﬁrst examined the effect of PF-228
on the maintenance of epithelial barrier function. Filter-grown mono-
layers were incubated in culture medium containing various doses
(3, 10 and 30 μM) of PF-228 and the change of TEER was measured.
As shown in Fig. 1A, vehicle and 3 μM PF-228 had no effect of TEER,
however, 10 and 30 μM PF-228 caused a dose-related decrease in
TEER. TEER was gradually decreased through 24 h to 96.3±2.6% for
3 μM, 81.8±1.2% for 10 μM, 65.9±1.3% for 30 μM PF-228 compared
to control. Previous studies have demonstrated an inverse relationship
between intestinal epithelial resistance and paracellular permeabilityFig. 1. Effect of PF-228 on Caco-2 monolayers permeability. (A) Time course of PF-228
effect on Caco-2 monolayer epithelial resistance. Filter-grown Caco-2 monolayers were
incubated with culture medium containing DMSO (vehicle) or the indicated concen-
tration of PF-228. (B) Effect of PF-228 on paracellular permeability of Caco-2 mono-
layers. Filter-grown Caco-2 monolayers were incubated with culture medium
containing DMSO (vehicle) or the indicated concentration of PF-228 for 4 h and the
lucifer yellow permeability was measured as described in Materials and methods.
(C) Effect of PF-228 on TEER recovery after the ethanol-induced barrier disruption.
Filter-grown Caco-2 monolayers were treated with 7.5% ethanol (vol/vol) for 30 min.
After ethanol removal, Caco-2 monolayers were incubated with culture medium
containing DMSO (vehicle) or the indicated concentration of PF-228 and TEER was
measured at the time indicated. TEER values were expressed relative to TEER before
ethanol treatment. Each value represents the mean±SEM determined from four to
six independent experiments. *pb0.05 versus control.in Caco-2 cell monolayers [27]. Therefore, we also examined the effect
of PF-228 on paracellular permeability by measuring the ﬂux rates of
a paracellular marker, lucifer yellow. After incubation with various
concentrations of PF-228 for 4 h, paracellular ﬂux of lucifer yellow
was signiﬁcantly increased in monolayers treated with 10 μM and
30 μM PF-228 to 1.6±0.2- and 2.6±0.6-fold, respectively (Fig. 1B).
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Fig. 2. Effect of PF-228 on FAK autophosphorylation in Caco-2 monolayers. (A) Time
course of PF-228 effect on autophosphorylation of FAK at Y397. Caco-2 monolayers
were incubated with 10 μM PF-228 for the indicated time. The autophosphorylation
of FAK was assessed by Western blot. PF-228 inhibited the autophosphorylation from
2 min (left panel) to 24 h (right panel). (B) Time course of PF-228 effect on the auto-
phosphorylation of FAK during the TEER recovery after ethanol treatment. Caco-2
monolayers were treated with ethanol as described in Fig. 1, and then incubated
with culture medium containing DMSO (vehicle) or 10 μM PF-228 for 1, 2 and 4 h.
We noted that the level of autophosphorylation was signiﬁcantly decreased by ethanol
treatment, and then increased again to original level after ethanol removal. PF-228
prevented the increase of autophosphorylation during TEER recovery.
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ment. We next investigated the effect of PF-228 on the recovery of epi-
thelial barrier function after functional epithelial damage.We employed
an ethanol-induced damage model, in which the treatment with low
noncytotoxic dose of ethanol produced a reversible modulation of
Caco-2 epithelial barrier function concomitant with the disruption of
TJ [23]. A 30-min ethanol treatment caused TEER decrease to about
50% compared with the value before treatment (Fig. 1C). After ethanol
removal, TEER recovered to the original level within 4 h. Although
a low dose (3 μM) of PF-228 had no effect on TEER recovery, higher
doses of PF-228 signiﬁcantly impaired TEER recovery in a dose-
dependent manner.
Next, we asked whether a decrease in autophosphorylation of FAK
at Y397 was accompanied by a decrease in TEER. Filter-grown mono-
layers were incubated in culture medium containing 10 μM PF-228.
As shown in Fig. 2A, PF-228 signiﬁcantly inhibited the autophospho-
rylation of FAK within 10 min and this inhibition was sustained
through 24 h. As shown in Fig. 2B, ethanol treatment of monolayers
caused transient decrease of FAK autophosphorylation. After ethanol
removal, FAK autophosphorylation was completely recovered to orig-
inal level within 4 h. The incubation in culture medium containing
10 μM PF-228 after ethanol removal inhibited the recovery of FAK
autophosphorylation.
3.2. Src regulates ethanol-induced TEER decrease and recovery by
phosphorylation of FAK
Autophosphorylation of FAK creates a Src homology 2 (SH2)-binding
site that together with a nearby proline-rich SH3-binding site can inter-
act with Src. The activation of Src in the FAK/Src complex leads to
further phosphorylation of Tyr576 and Tyr577 within the activation
loop of FAK kinase domain, which is known to potentiate FAK activity
[28]. Therefore, we postulated that FAK could structurally interact
with Src to form a protein complex in ethanol-induced disruption
and recovery of epithelial barrier function in Caco-2 monolayers. To
verify this hypothesis, we performed co-immunoprecipitation assay
using anti-FAK antibody. Western blot analysis showed that Src was
co-immunoprecipitated with FAK in control monolayers (Fig. 3A).
Ethanol treatment of monolayers caused not only the inhibition of
FAK autophosphorylation but also attenuation of Src binding to FAK.
By the incubation in culture medium with vehicle after removal of eth-
anol, the level of FAK autophosphorylation and Src binding returned
to control level within 30 min. In the presence of 10 or 50 μM PF-228,
FAK autophosphorylation and associating Src decreased. Western blotusing speciﬁc antibody against phospho-Tyr576/577 of FAK revealed
that phosphorylation of FAK activation loop was also attenuated in a
parallel manner during disruption and recovery of epithelial barrier.
These results suggested that the activation of FAK by Src was necessary
for the recovery of epithelial barrier function. Thus, we examined the ef-
fect of Src inhibitor, PP2, on TEER recovery. As shown in Fig. 3B, incuba-
tion in culture medium containing 10 μM PP2 after ethanol treatment
induced a signiﬁcant decrease of TEER recovery (pb0.003) in the early
phase (0.5 to 2 h). Western blot analysis showed that PP2 inhibited
the phosphorylation of FAK on Tyr576/577 (Fig. 3C, E), but not the auto-
phosphorylation of FAK on Tyr397 (Fig. 3C, D).
3.3. Localization of FAK in Caco-2 monolayers
To investigate the function of FAK in epithelial barrier function, we
examined the localization of FAK in Caco-2 monolayers by immuno-
ﬂuorescent microscopy. In the control monolayers, FAK was present
in the cellular periphery and appeared as a diffuse band localized at
the intercellular borders (Fig. 4A). Reconstruction of confocal image
in xz plane clearly showed the localization of FAK not only at the
basement/apical side but also at the cell–cell interface. Ethanol treat-
ment resulted in a formation of paracellular gaps and a translocation of
FAK away from the cell–cell interface to the apical surface of mono-
layers where signiﬁcant increase in ﬂuorescent intensity was observed
(Fig. 4B). After ethanol removal, the paracellular gaps closed and
FAK re-localized at the cell–cell interface of monolayers (Fig. 4C). The
incubation with 10 μMPF-228 after ethanol removal impaired the relo-
cation of FAK to the cell–cell interfaces from apical surface (Fig. 4D).We
also examined the localization of autophosphorylated FAK. Phospho-
FAK was diffusely stained near the cellular periphery in control mono-
layers (Fig. 4E). Ethanol treatment caused a signiﬁcant decrease of
phospho-FAK staining (Fig. 4F). After ethanol removal, phospho-FAK
staining increased again especially at the intercellular borders
(Fig. 4G), however, the incubation with 10 μM PF-228 after ethanol
removal caused a small increase of punctuate staining of phospho-FAK
in cytoplasm and did not show the localization at the cell–cell interface
(Fig. 4H).
3.4. FAK and claudin-1 distribution on sucrose gradients after
ethanol-induced disruption
According to the results of confocal imaging, we hypothesized
that FAK was one of the components of tight junction protein com-
plex. In order to test this hypothesis, we isolated the detergent-
insolublemembrane factions fromCaco-2 cells. Cell lysateswere loaded
under 5 to 40% discontinuous sucrose gradient. After ultracentrifuga-
tion, fractions were removed and analyzed by immunoblot for total
FAK, autophosphorylated FAK and claudin-1. In the control monolayers,
total and phospho-FAK were detected in buoyant fractions, especially
fractions 3 and 8, and load fraction 12 (Fig. 5A, B, control). A marker
of tight junction, claudin-1 also was strongly detected in fraction 3 cor-
responding to 15% sucrose, suggesting that this fraction contained tight
junction-enriched membrane (Fig. 5C, control). As shown in Fig. 5,
ethanol treatment caused distribution change of total and phosho-FAK
and claudin-1; both proteins were more strongly detected in fraction
8 and fractions 9 to 12 which were corresponding to loaded lysate
containing 40% sucrose. By incubation in control culture media after
ethanol removal, FAK and claudin-1 in fractions 8 and 9were decreased,
and in fractions 3 and 4 were increased. However, PF-228 impaired
these migrations. We also found that the level of FAK autophosphoryl-
ation in fraction 3 was changed by ethanol-induced barrier damage
and following barrier recovery in the absence or presence of PF-228;
ethanol treatment of monolayers caused decrease of FAK autophospho-
rylation. After ethanol removal, FAK autophosphorylation was recov-
ered to original level, however, PF-228 inhibited this recovery. These
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Fig. 3. Src regulates ethanol-induced TEER decrease and recovery via phosphorylation of FAK. (A) Phosphorylation-dependent interaction of FAK and Src. Caco-2 monolayers were
treated with ethanol as described in Fig. 1, and then incubated with culture medium containing DMSO (vehicle), 10 or 50 μM PF-228 for 30 min. The whole cell lysates were
immunoprecipitated with the FAK antibody. Total FAK, autophosphorylation of FAK (pFAK(Y397)), and phosphorylation of FAK by Src (pFAK(Y576/577)), and co-precipitated
Src were detected by Western blot (upper panel). Lysate was immunoblotted for total FAK and Src (lower panel). (B) Effect of PP2 on TEER recovery after the ethanol-induced
barrier disruption. After ethanol treatment of Caco-2 monolayers, cells were incubated with culture medium containing DMSO (vehicle) or 10 μM PP2, a selective inhibitor of
Src-family kinases. (C) Effect of PP2 on the FAK phosphorylation during TEER recovery. After treatment of Caco-2 monolayers as described above, the phosphorylation of FAK at
Y397 and at Y576/577 was assessed by Western blot. The phosphorylation levels of FAK at Y397 (D) and at Y576/577 (E) were determined by quantitative densitometric analysis.
Phosphorylation levels were normalized against those of total FAK, and the resulting ratios were expressed relative to those before treatment with ethanol. The lanes C and E
indicate before and after ethanol treatment, respectively. Each value represents the mean±SEM determined from three to four independent experiments. *pb0.05; **pb0.003 ver-
sus control.
155Y. Ma et al. / Biochimica et Biophysica Acta 1832 (2013) 151–159results indicated that FAK interacted with TJ and its distribution
might drastically change during epithelial barrier recovery.3.5. Effect of PF-228 on distribution of TJ proteins, ZO-1 and occludin
To determine whether PF-228 alters the distribution of TJ protein,
Caco-2 monolayers were treated with PF-228 (10 μM) for 2 h and la-
beled with anti-ZO-1 or anti-occludin antibody. In the untreated cells,
ZO-1 immunoﬂuorescence staining was localized at the cell borders
(Fig. 6A). Occludin was also localized at the cell borders, with some
punctate staining in the cytoplasm (Fig. 6B). However, incubation
with PF-228 caused a displacement of ZO-1 from cell borders, large
punctate staining in cytoplasm, and ring-like staining pattern adjacent
to cell–cell interface were observed (Fig. 6C). Staining of occludin be-
came irregular, discontinuous staining at cell borders and increased
punctate staining were observed (Fig. 6D). Next, we examined the
effect of PF-228 on ethanol-induceddisruption and recovery. In the con-
trol monolayers, ZO-1 and occludin staining were present in a continu-
ous band at the cell borders (Fig. 7A, B). Distribution of ZO-1 became
diffuse and the amount of punctate occludin increased after ethanol
treatment (Fig. 7C, D). After ethanol removal, ZO-1 and occludin rapidly
reassembled at the cellular borders (Fig. 7E, F). However, the addition of
PF-228 delayed the reassembly of the TJ proteins. In addition, diffusedistribution and many small ring-like staining of ZO-1 were observed
on cell borders (Fig. 7G). Staining of occludin became irregular, and
punctate staining still remained (Fig. 7H). These ﬁndings suggest that
PF-228 inhibits reassembly of ZO-1 and occludin at the cell border in
the recovery after ethanol-induced barrier injury, indicating that activa-
tion of FAK is associated with TJ during barrier recovery.3.6. Effect of FAK knockdown on Caco-2 monolayers permeability and
autophosphorylation of FAK
To conﬁrm the importance of FAK for epithelial barrier function, we
knocked down the expression of FAK in Caco-2 cells using speciﬁc
siRNA and examined the barrier function by measuring TEER. As
shown in Fig. 8A, both predesigned siRNAs for FAK (FAK siRNA Nos. 1
and 2) were efﬁciently suppressed in the protein expression of FAK at
4 days post-transfection. Quantitative densitometric analysis showed
that these siRNAs inhibited the expression of total FAK, which fell
to 37.9±1.9% and 52.0±2.1% respectively. At the same time TEER of
monolayers transfected with negative control siRNA was 389.9±
3.3 Ω·cm2. The knockdown of FAK caused statistically signiﬁcant de-
crease of TEER (379.3±2.7 Ω·cm2 for siRNA No. 1 and 374.4±
4.2 Ω·cm2 for siRNA No. 2, p=0.037 for both siRNA compared with
negative control TEER). We also examined the effect of knockdown
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Fig. 4. Differential localization of FAK in Caco-2 monolayers during barrier disruption and recovery. Caco-2 cells were labeled with anti-total FAK antibody (A to D) or
anti-phosphorylated FAK at Tyr397 (E to H) and visualized by confocal microscopy as described in Materials and methods. Caco-2 cells were untreated (A and E), or treated
with 7.5% ethanol for 30 min (B and F), and followed by incubation with culture medium containing DMSO (Vehicle) for 4 h (C and G) or with culture medium containing
10 μM PF-228 for 4 h (D and H). Lateral (xy, upper panels) and axial (xz, lower panels) sections obtained from the same area are shown. These results are representative of at
least three independent experiments. The arrowheads show the paracellular gaps on apical cell surface. Scale bars, 10 μm.
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autophosphorylated FAK increased by knockdown to 123.5±4.0% for
siRNA No. 1 and 128.6±7.3% for siRNA No. 2. Each p value compared
with negative control was 0.0026 and 0.023, respectively. These results
indicate that FAK contributes to the development of tight junction as-
sembly and the epithelial barrier formation.
4. Discussion
In this article, we examined the role of FAK in the epithelial barrier
function, employing a selective FAK inhibitor, PF-228. As shown in
Figs. 1 and 2, PF-228 decreased TEER and increased paracellular per-
meability in parallel with the inhibition of FAK autophosphorylation,
in Caco-2 monolayers. In addition, in the recovery after ethanol-
induced barrier injury, PF-228 treatment attenuated the recovery of
TEER (Fig. 1C) and prevented the increase in FAK phosphorylation
(Fig. 2B). These results suggest that FAK activity is required not only
to maintain but also to recover the barrier function.
Because it has been shown that binding of Src to FAK leads to full
activation of FAK [28], we examined the association of FAK with Src
and FAK phosphorylations by Src as well as FAK autophosphorylation.
Signiﬁcant levels of Src association and FAK phosphorylations were
recognized in Caco-2 monolayers. They decreased upon ethanol-
induced barrier injury and then recovered within 30 min (Fig. 3A).
These results suggested that the autophosphorylation of FAK, the
association of FAK with Src and the further phosphorylation of FAK
by Src are important events in the barrier function. In order to verify
this scheme, we examined the effects of PP2, a selective inhibitor of
Src family kinase. Our data showed that PP2 induced a statistically
signiﬁcant decrease of TEER recovery (Fig. 3B) accompanied with
an attenuation of phosphorylation on FAK Tyr576/577 that is cata-
lyzed by Src, but without affecting the autophosphorylation of FAK
(Fig. 3C–E). The reduction of TEER by PP2 was approximately 10%,
which was smaller than that by PF-228 that was 20–30% reduction
as shown in Fig. 1. We thus speculated that the inhibition of Src
prevented the tyrosine phosphorylation and the full activation of
FAK, leading to the delay of TEER recovery within 4 h. There are sev-
eral reports showing that the inactivation of Src reduced oxidativestress-induced epithelial barrier damage [29–31] and that PP2 atten-
uated ischemia-induced blood–brain barrier damage [32]. Although
they suggested either that Src activity augmented the barrier damage
or that Src inhibition facilitated the recovery of the barrier function
after 6 h of reperfusion, we speculate that our data in the early recov-
ery phase of barrier injury are not inconsistent with them, because
there may be different mechanisms in the damage phase and the re-
covery phase and in the late and early phase of barrier recovery.
An interesting ﬁnding in this study is that localization of FAK in
Caco-2 monolayers by immunoﬂuorescent microscopy showing that
ethanol caused a disappearance of FAK at cell–cell interface, and that
PF-228 inhibited the redistribution of FAK to the cell–cell interface
(Fig. 4). Because TJ is one of the most important components in the
epithelial barrier at the cell–cell interface, we hypothesized that FAK
correlated with barrier function via TJ. To test our hypothesis, ﬁrst,
we isolated the detergent-insoluble membrane fractions from Caco-2
monolayers by discontinuous sucrose density gradient ultracentrifuga-
tion (Fig. 5). FAK and claudin-1 were observed in the light density frac-
tions in the control, suggesting that FAK co-migrated with claudin-1 in
these fractions. Becausemembrane raft containing TJ proteins are sepa-
rated in these lower density fractions, these results indicate that FAK
is included in detergent-resistant microdomains. It is noteworthy that
ethanol treatment causes a shift of FAK distribution into heavy density
fractions corresponding to fraction numbers 9 to 12. After ethanol
removal, FAK redistributed to lower density. Addition of PF-228 also
prevented the redistribution and FAK remained in the fractions 9 to
12. The similar pattern was observed not only in phospho-FAK but
also in claudin-1. These results also support the change of FAK localiza-
tion by ethanol treatment as shown in Fig. 4. These ﬁndings suggest
the dynamic regulation of FAK activation and localization during epi-
thelial barrier recovery.
Furthermore, as shown in Fig. 6, PF-228 disrupted the assembly of
both ZO-1 and occludin at the cell border. In addition, PF-228 hampered
redistribution and reassembly of these TJ proteins in the recovery phase
of barrier injury (Fig. 7). These results indicate that FAK regulates the ep-
ithelial barrier function by reconstructing TJ proteins, at least ZO-1 and
occludin. This is consistent with the previous study that showed an
occludin/ZO-1/FAK complex, in which FAK is an integrated regulatory
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Fig. 5. Association of FAK with TJ fractions. Caco-2 monolayers were treated with
ethanol for 30 min and then incubated with the culture medium containing DMSO
(Vehicle) or 10 μM PF-228 for 1 h. Cell lysates that were prepared from each treated
Caco-2 monolayer were fractionated by sucrose density-gradient centrifuge into 12
fractions and detergent-insoluble membrane fractions were analyzed by Western blot
using anti-total FAK (A), anti-phosphorylated FAK at Tyr397 (B) and anti-claudin-1
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Fig. 6. Effect of PF-228 on localization of TJ proteins, ZO-1 and occludin. Caco-2 mono-
layers that were cultured on chamber slides were incubated in culture medium
containing vehicle (A and B) or 10 μM PF-228 (C and D) for 2 h. Localization of ZO-1
(A and C) and occludin (B and D) was examined by immunoﬂuorescence labeling
and confocal microscopy. Treatment with PF-228 caused obvious disrupted and dis-
continuous distribution (indicated by arrowheads) and punctate cytoplasmic immuno-
staining of ZO-1 and occludin (indicated by arrows). Scale bar, 10 μm.
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dynamics [15,16]. Yan et al. reported that these TJ proteins were
continuously endocytosed and recycled back to the Sertoli cell sur-
face via the clathrin-mediated pathway in blood–testis barrier [33].
Lastly, we tested siRNAs which are speciﬁc to FAK. As shown in
Fig. 8, knockdown of FAK resulted in signiﬁcant decrease in TEER of
Caco-2 monolayers. This is in accordance with the results obtained by
incubation with PF-228. The decrease was not comparable to the de-
crease of total FAK protein, however, the ratio of autophosphorylated
FAK increased as shown in Fig. 8C. We speculated that the decrease in
total FAK protein lead to an increase in the autophosphorylation of
FAK in order to compensate the reduction of FAK activity.
Recently, experimental and clinical studies suggest that disruption
and reassembly of TJ is an important component of diseases caused
by epithelial injury including IBD. Our previous study showed a posi-
tive correlation between FAK expression level in colonic epithelial
cells and the severity of chemical colitis, which suggested important
functions of FAK in epithelial cells during colitis formation and/or
wound repairing [19]. Lee et al. reported the important associations
between epithelial barrier function and kidney diseases [34]. The
proinﬂammatory cytokines in IBD such as TNFα and INF-γ can
downregulate the expression of occludin, causing barrier disturbance
[35]. TNFα also induced claudin-1 disassembly from tight junctionand increased claudin-2 expression mediated via a tyrosine kinase,
Akt and NF-κB pathways [36]. NF-κB also regulated the transcription
of FAK gene [17]. These studies suggest that the proinﬂammatory
cytokines alter the protein expression level of various TJ proteins
including FAK, and alter the integrity of epithelial barrier under patho-
logical conditions. Thus, further studies are needed to clarify the mech-
anismof the epithelial barrier disruption and to identify novelmolecular
target for pharmacological modulation of epithelial integrity.
It is well known that FAK also over-expressed in most human can-
cers, particularly in invasive and metastatic cancers. Therefore, FAK
has been proposed to be a target for anticancer therapy [37–40].
Thus, as inhibitor of FAK, PF-228 may apply an approach to treat can-
cer through FAK inhibition. However, according to our results, gastro-
intestinal adverse effects may occur during the treatment.
In conclusion, our data show for the ﬁrst time that PF-228 induced
an increase in epithelial barrier permeability and TJ disassembly in
Caco-2 monolayer. Inhibition of FAK activity is likely to be a crucial
mechanism in the signaling pathway leading to the decreased TEER,
increased permeability and TJ disassembly, both functionally and
morphologically. Thus, our data show that FAK activity is a key ele-
ment in the maintenance and repair of intestinal epithelial barrier
function, regulating the assembly and distribution of TJ proteins.Acknowledgements
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